{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:40:37Z","timestamp":1790458837883,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jaad.2017.04.1127","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T17:32:34Z","timestamp":1498239154000},"page":"448-455.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prescription patterns and costs of acne\/rosacea medications in Medicare patients vary by prescriber specialty"],"prefix":"10.1016","volume":"77","author":[{"given":"Myron","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Kaffenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2017.04.1127_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/09546634.2013.851921","article-title":"Patterns of ambulatory care usage and leading treatments for rosacea","volume":"25","author":"Davis","year":"2014","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.jaad.2017.04.1127_bib2","first-page":"41","article-title":"Healthcare utilization and costs of patients with rosacea in an insured population","volume":"7","author":"Romanowicz","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.04.1127_bib3","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jaad.2016.01.011","article-title":"Use of topical retinoids by dermatologists and non-dermatologists in the management of acne vulgaris","volume":"74","author":"Pena","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.04.1127_bib4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.04.1127_bib5","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaad.2016.06.057","article-title":"Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among general practitioners (GP): a retrospective cohort study","volume":"75","author":"Barbieri","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.04.1127_bib6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/pde.12201","article-title":"Treatment of preadolescent acne in the United States: an analysis of nationally representative data","volume":"30","author":"Davis","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.04.1127_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1525-1470.2008.00790.x","article-title":"Differences in acne treatment prescribing patterns of pediatricians and dermatologists: an analysis of nationally representative data","volume":"25","author":"Yentzer","year":"2008","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2017.04.1127_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/09546630801955176","article-title":"Prescription refills and healthcare costs associated with topical metronidazole in Medicaid enrolled patients with rosacea","volume":"19","author":"Jayawant","year":"2008","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"10.1016\/j.jaad.2017.04.1127_bib9","first-page":"766","article-title":"Medication choice and associated health care outcomes and costs for patients with acne and acne-related conditions in the United States","volume":"10","author":"Patel","year":"2011","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.04.1127_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40257-013-0016-x","article-title":"Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris","volume":"14","author":"Tan","year":"2013","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.04.1127_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/09546630802314662","article-title":"The cost-effectiveness of rosacea treatments","volume":"20","author":"Thomas","year":"2009","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"10.1016\/j.jaad.2017.04.1127_bib12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2016.11.052","article-title":"The cost of topical immunomodulator therapy in Medicare patients varies by prescriber specialty","volume":"76","author":"Zhang","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1127_bib13","unstructured":"Centers for Medicare & Medicaid Services. 2008 and 2010 Prescription Drug Profiles Public Use Files. Available at: https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and-Reports\/BSAPUFS\/Prescription_Drug_Profiles.html. Accessed February 9, 2016."},{"key":"10.1016\/j.jaad.2017.04.1127_bib14","unstructured":"Centers for Medicare & Medicaid Services. 2014 Medicare provider utilization and payment data: part D Prescriber Public Use File. Available at: https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and-Reports\/Medicare-Provider-Charge-Data\/PartD2014.html. Accessed December 29, 2016."},{"key":"10.1016\/j.jaad.2017.04.1127_bib15","unstructured":"Bureau of Labor Statistics, US Department of Labor. CPI detailed Rep: data for April 2016. Available at: http:\/\/www.bls.gov\/cpi\/cpid1604.pdf. Accessed June 4, 2016."},{"issue":"8","key":"10.1016\/j.jaad.2017.04.1127_bib16","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/archderm.144.8.988","article-title":"A community-based study of acne-related health preferences in adolescents","volume":"144","author":"Chen","year":"2008","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.04.1127_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jama.283.3.373","article-title":"Physicians and the pharmaceutical industry: is a gift ever just a gift?","volume":"283","author":"Wazana","year":"2000","journal-title":"Jama"},{"issue":"11","key":"10.1016\/j.jaad.2017.04.1127_bib18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1525-1497.1999.01049.x","article-title":"Direct-to-consumer prescription drug advertising and the public","volume":"14","author":"Bell","year":"1999","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1016\/j.jaad.2017.04.1127_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jamadermatol.2013.9715","article-title":"Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea","volume":"150","author":"Hurley","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.04.1127_bib20","first-page":"317","article-title":"Metronidazole in the treatment of rosacea: do formulation, dosing, and concentration matter?","volume":"5","author":"Yoo","year":"2006","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.04.1127_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2017.04.1127_bib22","unstructured":"Medicaid. 2017 national average drug acquisition cost. Available at: https:\/\/www.medicaid.gov\/medicaid\/prescription-drugs\/pharmacy-pricing\/index.html. Accessed March 27, 2017."}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217316602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217316602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:43:57Z","timestamp":1759272237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217316602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0190962217316602"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.04.1127","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727752689.793536615","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescription patterns and costs of acne\/rosacea medications in Medicare patients vary by prescriber specialty","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.04.1127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}